Solara Active Pharma Sciences Ltd
NSE: SOLARA BSE: 541540
₹425.55
(-3.87%)
Fri, 10 Apr 2026, 05:01 am
Market Cap20.48B
PE Ratio0
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KSolara Active Pharma Sciences Financials
| Particulars | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 5.21B | 13.87B | 13.22B | 15.97B | 12.63B | 14.27B | 12.74B | 12.69B |
| Gross profit | 0 | 736.27M | 2.63B | 2.77B | 3.81B | 1.00B | 1.25B | -1.30B | 1.86B |
| Operating expenses (excl. COGS) | -33.00K | -446.43M | -1.13B | -1.06B | -1.19B | -1.34B | -1.16B | -2.55B | -928.60M |
| Selling/general/admin expenses, total | -17.00K | -438.56M | -1.10B | -1.02B | -1.18B | -1.32B | -1.14B | -1.30B | -910.10M |
| Research & development | — | -18.18M | -440.50M | -474.70M | -529.10M | -540.90M | -355.90M | -495.20M | -344.80M |
| Selling/general/admin expenses, other | -17.00K | -420.38M | -661.10M | -543.50M | -649.00M | -777.00M | -783.20M | -804.70M | -565.30M |
| Other operating expenses, total | -16.00K | -7.87M | -23.70M | -44.90M | -15.70M | -19.30M | -23.10M | -1.25B | -18.50M |
| Operating income | -33.00K | 289.84M | 1.51B | 1.71B | 2.62B | -332.80M | 85.60M | -3.85B | 935.10M |
| Non-operating income, total | 0 | -231.57M | -830.80M | -556.60M | -403.00M | -578.20M | -533.80M | -1.03B | -929.70M |
| Interest expense, net of interest capitalized | 0 | -251.36M | -823.50M | -776.50M | -843.70M | -698.00M | -866.40M | -1.04B | -1.11B |
| Interest capitalized | 0 | 0 | 8.10M | 96.50M | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 0 | 11.58M | -36.00M | 128.80M | 399.80M | 132.60M | 224.00M | 155.70M | 127.60M |
| Non-operating interest income | 0 | 3.30M | 16.10M | 76.20M | 142.20M | 77.60M | 57.80M | 22.20M | 7.60M |
| Miscellaneous non-operating expense | 0 | 8.28M | -52.10M | 52.60M | 257.60M | 55.00M | 166.20M | 133.50M | 120.00M |
| Unusual income/expense | 0 | 8.21M | 28.70M | 91.10M | 40.90M | -12.80M | 108.60M | -151.30M | 48.90M |
| Pretax income | -33.00K | 58.27M | 676.70M | 1.15B | 2.21B | -911.00M | -448.20M | -4.88B | 5.40M |
| Taxes | 0 | 1.40M | -5.80M | -3.90M | -1.50M | 328.10M | 225.70M | -785.40M | 0 |
| Non-controlling/minority interest | 0 | 400.00K | 1.00M | 900.00K | 500.00K | 1.40M | 700.00K | -4.30M | 0 |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | -33.00K | 60.07M | 671.90M | 1.15B | 2.21B | -581.50M | -221.80M | -5.67B | 5.40M |
| Net income | -33.00K | 3.77M | 595.10M | 1.15B | 2.21B | -581.50M | -221.80M | -5.67B | 5.40M |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | -33.00K | 3.77M | 595.10M | 1.15B | 2.21B | -581.50M | -221.80M | -5.67B | 5.40M |
| Basic earnings per share (Basic EPS) | -3.04 | 0.31 | 22.21 | 40.82 | 63.59 | -14.91 | -5.68 | -145.27 | 0.14 |
| Diluted earnings per share (Diluted EPS) | -3.04 | 0.31 | 22.18 | 39.46 | 59.47 | -14.91 | -5.68 | -145.27 | 0.14 |
| EBITDA | -33.00K | 629.67M | 2.33B | 2.64B | 3.70B | 783.60M | 1.19B | -2.83B | 1.93B |
| EBIT | -33.00K | 289.84M | 1.51B | 1.71B | 2.62B | -332.80M | 85.60M | -3.85B | 935.10M |
| Total operating expenses | -33.00K | -4.92B | -12.36B | -11.51B | -13.35B | -12.97B | -14.18B | -16.59B | -11.76B |
| Prepaid expenses | — | 79.90M | 61.30M | 73.20M | 156.50M | 84.10M | 99.90M | 114.20M | 162.30M |
| Deferred income, current | — | 160.43M | 240.00M | 184.10M | 141.00M | 179.80M | 74.30M | 41.90M | 7.80M |
| Capital and operating lease obligations | 0 | 38.10M | 127.60M | 127.60M | 117.70M | 111.50M | 111.50M | 116.10M | 177.70M |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | — | 484.32M | 328.30M | 118.30M | — | 808.50M | 833.10M | 0 | — |
| Deferred income, non-current | — | 0 | 569.90M | 427.40M | 284.90M | 231.30M | 0 | — | — |
| Minority interest | 0 | 44.80M | 43.80M | 42.90M | 42.40M | 23.10M | 22.40M | 26.70M | 26.70M |
| Change in accrued expenses | — | — | — | — | — | — | — | — | — |
| Common dividends paid | 0 | 0 | 0 | -156.20M | -197.30M | -107.80M | 0 | 0 | 0 |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800